
    
      Two groups of unexplained recurrent spontaneous abortion, each included 65 participants.
      scheduled randomly into; the study group received Sildenafil Citrate and Placebo group. The
      intervention started from day 21-23 of the cycle preceding spontaneous pregnancy and
      continued till the 12th-week of gestation.

      The primary outcome measure was the difference in the live birth between both groups.
      Secondary outcome measures were the differences between both groups regard PI and RI, a
      number of take-home babies, the reported side-effects of treatment and the pregnancy-related
      complications, e.g., preeclampsia and intrauterine growth restriction (|IUGR).
    
  